author_facet De Benedetti, F
Brunner, HI
Baildam, E
Burgos-Vargas, R
Horneff, G
Huppertz, HI
Minden, K
Myones, BL
Onel, K
Wang, J
Bharucha, K
Lovell, D
Martini, A
Ruperto, N
De Benedetti, F
Brunner, HI
Baildam, E
Burgos-Vargas, R
Horneff, G
Huppertz, HI
Minden, K
Myones, BL
Onel, K
Wang, J
Bharucha, K
Lovell, D
Martini, A
Ruperto, N
author De Benedetti, F
Brunner, HI
Baildam, E
Burgos-Vargas, R
Horneff, G
Huppertz, HI
Minden, K
Myones, BL
Onel, K
Wang, J
Bharucha, K
Lovell, D
Martini, A
Ruperto, N
spellingShingle De Benedetti, F
Brunner, HI
Baildam, E
Burgos-Vargas, R
Horneff, G
Huppertz, HI
Minden, K
Myones, BL
Onel, K
Wang, J
Bharucha, K
Lovell, D
Martini, A
Ruperto, N
Pediatric Rheumatology
PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
Immunology and Allergy
Rheumatology
Pediatrics, Perinatology and Child Health
author_sort de benedetti, f
spelling De Benedetti, F Brunner, HI Baildam, E Burgos-Vargas, R Horneff, G Huppertz, HI Minden, K Myones, BL Onel, K Wang, J Bharucha, K Lovell, D Martini, A Ruperto, N 1546-0096 Springer Science and Business Media LLC Immunology and Allergy Rheumatology Pediatrics, Perinatology and Child Health http://dx.doi.org/10.1186/1546-0096-11-s2-p152 PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) Pediatric Rheumatology
doi_str_mv 10.1186/1546-0096-11-s2-p152
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNTQ2LTAwOTYtMTEtczItcDE1Mg
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNTQ2LTAwOTYtMTEtczItcDE1Mg
institution DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
imprint Springer Science and Business Media LLC, 2013
imprint_str_mv Springer Science and Business Media LLC, 2013
issn 1546-0096
issn_str_mv 1546-0096
language English
mega_collection Springer Science and Business Media LLC (CrossRef)
match_str debenedetti2013presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia
publishDateSort 2013
publisher Springer Science and Business Media LLC
recordtype ai
record_format ai
series Pediatric Rheumatology
source_id 49
title PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_unstemmed PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_full PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_fullStr PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_full_unstemmed PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_short PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_sort pres-final-2140: neutropenia with tocilizumab (tcz) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (sjia)
topic Immunology and Allergy
Rheumatology
Pediatrics, Perinatology and Child Health
url http://dx.doi.org/10.1186/1546-0096-11-s2-p152
publishDate 2013
physical
description
container_issue S2
container_start_page 0
container_title Pediatric Rheumatology
container_volume 11
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792323179275878402
geogr_code not assigned
last_indexed 2024-03-01T11:29:23.519Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=PReS-FINAL-2140%3A+Neutropenia+with+Tocilizumab+%28TCZ%29+treatment+is+not+associated+with+increased+infection+risk+in+patients+with+systemic+juvenile+idiopathic+arthritis+%28SJIA%29&rft.date=2013-12-01&genre=article&issn=1546-0096&volume=11&issue=S2&jtitle=Pediatric+Rheumatology&atitle=PReS-FINAL-2140%3A+Neutropenia+with+Tocilizumab+%28TCZ%29+treatment+is+not+associated+with+increased+infection+risk+in+patients+with+systemic+juvenile+idiopathic+arthritis+%28SJIA%29&aulast=Ruperto&aufirst=N&rft_id=info%3Adoi%2F10.1186%2F1546-0096-11-s2-p152&rft.language%5B0%5D=eng
SOLR
_version_ 1792323179275878402
author De Benedetti, F, Brunner, HI, Baildam, E, Burgos-Vargas, R, Horneff, G, Huppertz, HI, Minden, K, Myones, BL, Onel, K, Wang, J, Bharucha, K, Lovell, D, Martini, A, Ruperto, N
author_facet De Benedetti, F, Brunner, HI, Baildam, E, Burgos-Vargas, R, Horneff, G, Huppertz, HI, Minden, K, Myones, BL, Onel, K, Wang, J, Bharucha, K, Lovell, D, Martini, A, Ruperto, N, De Benedetti, F, Brunner, HI, Baildam, E, Burgos-Vargas, R, Horneff, G, Huppertz, HI, Minden, K, Myones, BL, Onel, K, Wang, J, Bharucha, K, Lovell, D, Martini, A, Ruperto, N
author_sort de benedetti, f
container_issue S2
container_start_page 0
container_title Pediatric Rheumatology
container_volume 11
description
doi_str_mv 10.1186/1546-0096-11-s2-p152
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNTQ2LTAwOTYtMTEtczItcDE1Mg
imprint Springer Science and Business Media LLC, 2013
imprint_str_mv Springer Science and Business Media LLC, 2013
institution DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15
issn 1546-0096
issn_str_mv 1546-0096
language English
last_indexed 2024-03-01T11:29:23.519Z
match_str debenedetti2013presfinal2140neutropeniawithtocilizumabtcztreatmentisnotassociatedwithincreasedinfectionriskinpatientswithsystemicjuvenileidiopathicarthritissjia
mega_collection Springer Science and Business Media LLC (CrossRef)
physical
publishDate 2013
publishDateSort 2013
publisher Springer Science and Business Media LLC
record_format ai
recordtype ai
series Pediatric Rheumatology
source_id 49
spelling De Benedetti, F Brunner, HI Baildam, E Burgos-Vargas, R Horneff, G Huppertz, HI Minden, K Myones, BL Onel, K Wang, J Bharucha, K Lovell, D Martini, A Ruperto, N 1546-0096 Springer Science and Business Media LLC Immunology and Allergy Rheumatology Pediatrics, Perinatology and Child Health http://dx.doi.org/10.1186/1546-0096-11-s2-p152 PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA) Pediatric Rheumatology
spellingShingle De Benedetti, F, Brunner, HI, Baildam, E, Burgos-Vargas, R, Horneff, G, Huppertz, HI, Minden, K, Myones, BL, Onel, K, Wang, J, Bharucha, K, Lovell, D, Martini, A, Ruperto, N, Pediatric Rheumatology, PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA), Immunology and Allergy, Rheumatology, Pediatrics, Perinatology and Child Health
title PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_full PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_fullStr PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_full_unstemmed PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_short PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
title_sort pres-final-2140: neutropenia with tocilizumab (tcz) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (sjia)
title_unstemmed PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
topic Immunology and Allergy, Rheumatology, Pediatrics, Perinatology and Child Health
url http://dx.doi.org/10.1186/1546-0096-11-s2-p152